Percutaneous Renal Sympathetic Denervation for the Treatment of Resistant Hypertension with Heart Failure: First Experience in Korea

다국어 초록 (Multilingual Abstract)

Percutaneous catheter-based therapy has recently been introduced to decrease blood pressure by ablation of efferent and afferent sympathetic renal nerves. The patient described here had a seven-year history of hypertension and presented with poorly controlled blood pressure despite antihypertensive therapy with four different drugs. A 44-yr-old man underwent percutaneous renal denervation under local anesthesia using an ablation catheter. After six months of follow-up his blood pressure had dropped 49/37mmHg with a decrease in 24-hr ambulatory BP of 20/18 mmHg. Renal Doppler ultrasound showed no significant stenosis in either renal artery. This is the first case of successful percutaneous renal denervation, which has recently become available in Korea.

참고문헌 (Reference)

1 DiBona GF, "The sympathetic nervous system and hypertension: recent developments" 43 : 147-150, 2004

2 Sobotka PA, "The role of renal denervation in the treatment of heart failure" 14 : 285-292, 2012

3 Mancia G, "Sympathetic activation in the pathogenesis of hypertension and progression of organ damage" 34 : 724-728, 1999

4 Symplicity HTN-2 Investigators, "Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial" 376 : 1903-1909, 2010

5 Mahfoud F, "Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension" 60 : 419-424, 2012

6 Thomas G, "Renal denervation to treat resistant hypertension: guarded optimism" 79 : 501-510, 2012

7 Schlaich MP, "Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept" 54 : 1195-1201, 2009

8 Voskuil M, "Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience" 19 : 319-323, 2011

9 Davies JE, "First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot Study" 162 : 189-192, 2013

10 Krum H, "Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study" 373 : 1275-1281, 2009

11 Mancia G, "2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESHESC task force on the management of arterial hypertension" 25 : 1751-1762, 2007